Theriva Biologics Inc banner

Intrinsic Value

Not Available for TOVX

There is not enough data to reliably calculate the intrinsic value for Theriva Biologics Inc.

Do our valuations actually work? See backtest results .

Alternatives to TOVX

Fundamental Analysis

What Theriva Biologics Does

Biotechnology Health Care

Theriva Biologics is a clinical-stage biotechnology company that develops cancer treatments, mainly virus-based therapies designed to attack tumor cells and make standard drugs work better. Its lead program, VCN-01, is an engineered adenovirus meant to spread inside solid tumors and help destroy cancer from within.

Headquarters
United States of America US
Employees
21
IPO date
Feb 12, 1993
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Theriva Biologics Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

TOVX Insider Trading
Buy and sell transactions by insiders